UTMB Health Department of Surgery Homepage Banner

Surgical Sciences


UTMB Surgery team attends ATC 2022

Transplant Team Attends 2022 American Transplant Congress

Jun 30, 2022, 16:15 PM by UTMB Surgery

Members of the Division of Transplant Surgery attended the recent meeting of the American Transplant Congress (ATC) in Boston, Massachusetts.


    The American Transplant Congress is the Joint Annual Meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST). ATC provides a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation and brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals. The educational offerings provide attendees the opportunity to learn cutting-edge advances in research and exchange of ideas and practice in the field of solid organ and tissue transplantation.

    -The ATC Website

Learn more about the American Transplant Congress

    • Dr. Engebretsen attends ATC 2022
    • UTMB Surgery team attends ATC 2022
    • Dr. Engebretsen in front of a poster at ATC 2022
    • Group photo at ATC 2022
    • Dr. Kueht at ATC 2022
    • UTMB Surgery team attends ATC 2022



    UTMB Members at ATC 2022


    Oral Presentation:

    1)Intraoperative Kinetics of Pro-Inflammatory Markers and Delayed-Graft Function During Kidney Transplantation

    P. A. Wadsworth, O. Saldarriaga, D. Millian, WS. Fagg, J. Fair, M. Cusick, M. Mujtaba, D. Pena, D. Mann, H. L. Stevenson, M. L. Kueht



    1) Monitoring of Kidney Allograft Rejection Using Patient-Centric State-of-the-Art Tools - An Approach to Early Diagnosis and InterventionA. Rizvi, A. Gamilla-Crudo, S. A. Hussain, M. Kueht, J. Fair, M. Mujtaba


    2) Antibody-Mediated Kidney Allograft Rejection (ABMR) Monitoring and Intervention Based on ABMR Subtypes - A Step Towards Precision Diagnosis and Management

    A. Rizvi, S. Hussain, M. Kueht, J. Fair, A. Gamilla-Crudo, M. Mujtaba


    3) Post Transplant Virologic Outcomes in DCD Kidney Transplant Recipients Treated with Thymoglobulin Induction Immunosuppression and Maintenance Belatacept vs Calcineurin Inhibitor Therapy

    T. Engebretsen, M. Kueht, A. Lea, M. Mujtaba, S. Hussain, A. Rizvi, M. Mujtaba


    4) Factors Linked with Evaluation to Wait Listing for Referred Patients at the University of Texas Medical Branch’s Main Center and Outreach Clinic - A Step Towards Kidney Transplantation

    A. Rizvi, M. Mujtaba, S. Hussain, J. Fair, M. Kueht, A. Gamilla-Crudo


    5) Direct Comparison of Clinical Outcomes with Belatacept-Based Regimens to Calcineurin Inhibitors Among DCD and/or High KDPI Kidney Transplant Recipients

    A. Rizvi, M. Kueht, S. Hussain, J. Fair, R. Ramirez, A. Gamilla-Crudo, M. Mujtaba


    6) Impact of Immunosuppressive Medications on SARS-CoV-2 Vaccination Response in Kidney Transplant Patients

    O. Sogbein, A. Rizvi, M. Mujtaba, M. Kueht, J. Fair, A. Gamilla-Crudo, S. Hussain


    7) Cell-free amniotic fluid reduces liver inflammation and fibrosis

    F. Ditmars, C. M. Bowen, N. Liu, K. L. Pereira de Castro, M. Kueht, A. Saad, H. Lerner-Stevenson, W. S. Fagg, J. Fair